Back
Promotora Y Operadora de Infraestructura SAB de CV Vs. Keros Therapeutics Industry Stock Comparison
Buy
65
PUODY
Promotora Y Operadora de Infraestructura SAB de CV
Last Price:
187.14
Seasonality Move:
1.38%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.44
Seasonality Move:
4.22%
Buy
65
Promotora Y Operadora de Infraestructura SAB de CV (PUODY)
is a Buy
Is Promotora Y Operadora de Infraestructura SAB de CV a Buy, Sell or Hold?
- The current Promotora Y Operadora de Infraestructura SAB de CV [PUODY] share price is $190.00. The Score for PUODY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PUODY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PUODY Stock Price Chart
What is Promotora Y Operadora de Infraestructura SAB de CV's stock price today?
-
The Promotora Y Operadora de Infraestructura SAB de CV share price today is $190.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PUODY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
PUODY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.87 | Sell |
| Relative Strength Index (14 RSI): | 40.68 | Sell |
| Chaikin Money Flow: | 14 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (189.36 - 222.46) | Sell |
| Bollinger Bands (100): | (200.21 - 222.75) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.91 | Sell |
| Relative Strength Index (14 RSI): | 36.74 | Sell |
| Chaikin Money Flow: | -120480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.18 - 50.06) | Sell |
| Bollinger Bands (100): | (50.42 - 64.92) | Sell |
PUODY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 190.52 | Sell |
| 20-day SMA: | 200.4 | Sell |
| 50-day SMA: | 209.48 | Sell |
| 200-day SMA: | 200.49 | Sell |
| 8-day EMA: | 192.76 | Sell |
| 20-day EMA: | 199.07 | Sell |
| 50-day EMA: | 206.58 | Sell |
| 200-day EMA: | 203.79 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.5 | Sell |
| 20-day SMA: | 47.57 | Sell |
| 50-day SMA: | 52.43 | Sell |
| 200-day SMA: | 46.94 | Sell |
| 8-day EMA: | 46.46 | Sell |
| 20-day EMA: | 48 | Sell |
| 50-day EMA: | 51.59 | Sell |
| 200-day EMA: | 50.14 | Sell |
Promotora Y Operadora de Infraestructura SAB de CV Earnings Growth & PUODY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Promotora Y Operadora de Infraestructura SAB de CV Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||